CSIMarket
 


Genocea Biosciences Inc   (GNCA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Genocea Biosciences Inc 's Leverage Ratio

GNCA's quarterly Leverage Ratio and Total Liabilities, Equity growth




GNCA Leverage Ratio (Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
Y / Y Equity Change -35.6 % -79.09 % 108.71 % 241.4 % 382.81 %
Y / Y Total Liabilities Change 349.97 % 0.48 % 58.28 % 67.17 % 19.83 %
Leverage Ratio MRQ 4.26 4.04 2.47 1.1 0.61
Overall Ranking # # # # #
Seq. Equity Change 151.4 % -38.24 % -48.04 % -20.18 % -18.38 %
Seq. Total Liabilities Change 164.76 % 0.93 % 16.72 % 44.26 % -40.88 %



Leverage Ratio third quarter 2020 Comment
Due to net new borrowings of 164.76%, Leverage Ratio detoriated to 4.26, above company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the third quarter 2020, 67 other companies have achieved lower Leverage Ratio than Genocea Biosciences Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are GNCA Customers?
Leverage Ratio third quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 68
Healthcare Sector # 359
Overall Market # 1876


Leverage Ratio Statistics
High Average Low
4.89 1.32 0.14
(Sep 30 2017)   (Sep 30 2015)




Financial Statements
Genocea Biosciences Inc 's Equity $ 20 Millions Visit GNCA's Balance sheet
Genocea Biosciences Inc 's Total Liabilities $ 86 Millions Visit GNCA's Balance sheet
Source of GNCA's Sales Visit GNCA's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingSep 30 2020, within Biotechnology & Drugs Industry Leverage RatioSep 30 2020 MRQ Total LiabilitiesSep 30 2020 MRQ Equity
Cannapharmarx Inc   10.26 $ 14.988  Millions$ 1.461  Millions
Abbvie Inc   8.49 $ 129,866.000  Millions$ 15,289.000  Millions
Novavax Inc  7.87 $ 837.580  Millions$ 106.440  Millions
Quotient Limited  7.07 $ 238.185  Millions$ 33.710  Millions
Cytomx Therapeutics Inc   6.81 $ 327.118  Millions$ 48.064  Millions
Apollo Endosurgery inc   6.74 $ 70.274  Millions$ 10.419  Millions
Navidea Biopharmaceuticals Inc   6.46 $ 5.826  Millions$ 0.901  Millions
Outlook Therapeutics Inc   5.98 $ 16.906  Millions$ 2.826  Millions
Aerie Pharmaceuticals Inc   5.10 $ 306.589  Millions$ 60.097  Millions
Amgen Inc   4.88 $ 53,468.000  Millions$ 10,959.000  Millions
Cellular Biomedicine Group Inc   4.37 $ 75.763  Millions$ 17.324  Millions
Halozyme Therapeutics Inc   4.29 $ 425.041  Millions$ 98.988  Millions
Genocea Biosciences Inc   4.26 $ 85.993  Millions$ 20.205  Millions
Biocryst Pharmaceuticals Inc  4.24 $ 142.589  Millions$ 33.637  Millions
Vistagen Therapeutics Inc   3.80 $ 16.048  Millions$ 4.223  Millions
Vitality Biopharma Inc   3.76 $ 1.154  Millions$ 0.306  Millions
Galera Therapeutics Inc   2.97 $ 73.380  Millions$ 24.695  Millions
Avantor Inc   2.60 $ 6,625.400  Millions$ 2,552.300  Millions
Integrated Biopharma Inc  2.46 $ 17.514  Millions$ 7.116  Millions
Gilead Sciences Inc   2.29 $ 40,090.000  Millions$ 17,471.000  Millions
Nanostring Technologies Inc   2.24 $ 230.222  Millions$ 102.595  Millions
Reynolds Consumer Products Inc   2.05 $ 3,173.000  Millions$ 1,551.000  Millions
Champions Oncology Inc   1.88 $ 12.935  Millions$ 6.893  Millions
Coherus Biosciences inc   1.80 $ 461.312  Millions$ 255.731  Millions
Bionano Genomics Inc   1.79 $ 26.220  Millions$ 14.676  Millions
Neuronetics Inc   1.71 $ 47.059  Millions$ 27.478  Millions
Adma Biologics Inc   1.66 $ 118.600  Millions$ 71.376  Millions
Scholar Rock Holding Corp  1.59 $ 100.444  Millions$ 62.977  Millions
Sunwin Stevia International Inc   1.56 $ 17.736  Millions$ 11.338  Millions
Merus N v   1.53 $ 128.992  Millions$ 84.501  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

STE's Profile

Stock Price

STE's Financials

Business Description

Fundamentals

Charts & Quotes

STE's News

Suppliers

STE's Competitors

Customers & Markets

Economic Indicators

STE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071